Colorectal cancer: 'Don't be embarrassed to death'

Mar 18, 2011

(PhysOrg.com) -- UC Irvine Healthcare reminds people not to ignore the health of their digestive tract during Colorectal Cancer Awareness month.

“Colorectal is the second leading cause of cancer death in the U.S., but it doesn’t have to be,” says Dr. Michael Stamos, chair of UC Irvine’s Department of Surgery and president-elect of the American Board of Colon and Rectal Surgery. “The good news is that it’s preventable, treatable and curable.”

Recently, Stamos appeared on a CBS Healthwatch webcast with five other nationally recognized experts. The program, introduced by CBS news anchor Katie Couric and hosted by Dr. Travis Stork of the TV show “The Doctors,” may be seen at newyork.cbslocal.com/healthwatch-live-stream/ .

Stamos and fellow panelists addressed prevention, benefits of screening and colonoscopy, digestive conditions and their relation to colorectal cancer, digestive diseases, and treatment options, especially minimally invasive laparoscopic surgery and it’s overall underutilization. Stamos says there are not enough highly trained colorectal surgeons to fill the need. Most cases are performed by general surgeons who may not have a high enough volume of patients be fully proficient in laparoscopy.

Some people are reluctant to get a colonoscopy or speak to their doctor about colorectal health because they’re embarrassed to talk about that area of their body, he says. According to the Centers for Disease Control and Prevention, as many as 60 percent of colorectal cancer deaths could be prevented if men and women 50 or older were screened routinely.

“Don’t be a statistic,” says Stamos. “Don’t be embarrassed to death.”

Many colon cancer cases have no symptoms. However, the following may indicate colon cancer:

• Abdominal pain and tenderness in the lower abdomen
• Blood in the stool
• Diarrhea, constipation, or other change in bowel habits
• Intestinal obstruction
• Narrow stools
• Unexplained anemia
• Weight loss with no known reason

Screening for colorectal cancer is recommended beginning at age 50. Guidelines include the following tests:

• Colonoscopy every 10 years.
• High-sensitivity fecal occult blood test, also known as a stool test, yearly.
• Flexible sigmoidoscopy every 5 years.

Ask your primary care doctor the following questions about colorectal health and digestive diseases:

• Do I need a screening test for colorectal cancer?
• What screening test(s) do you recommend?
• How do I prepare? Do I need to change my diet or medication schedule?
• What’s involved in the test? Will it be uncomfortable or painful?
• Is there any risk?
• When and from whom will I get results?

Stamos says the current standard of colonoscopy screening at 50 years old may be changing, particularly for high-risk patients with inflammatory bowel disease or personal or family history of colorectal cancer or polyps.

“More than 90 percent of the cancers appear in people over 50, but we’re seeing more and more people with colorectal health issues in their 40s,” Stamos says. “A lot has to do with your family history.”

Explore further: New colonoscope provides ground-breaking view of colon

add to favorites email to friend print save as pdf

Related Stories

Knowing Risk Factors Can Prevent Colon Cancer

Jul 13, 2010

(PhysOrg.com) -- Colorectal cancer is the third biggest cancer killer in the United States, killing an estimated 50,000 people every year, according to the American Caner Society.

The Medical Minute: Osteoporosis

May 26, 2010

Osteoporosis is a disease in which bones become thin. As a result, the bones are more likely to break. Bones most often affected are in the hip, spine and wrist, but the ribs and other bones also are at risk.

Recommended for you

New colonoscope provides ground-breaking view of colon

11 minutes ago

A ground-breaking advance in colonoscopy technology signals the future of colorectal care, according to research presented today at Digestive Disease Week(DDW). Additional research focuses on optimizing the minimal withdrawal ...

ASCO: combo antibody therapy effective for melanoma

19 hours ago

(HealthDay)—Concurrent use of two immune checkpoint antibodies—ipilimumab and nivolumab—may be effective for the treatment of advanced melanoma, according to a proof-of-principal study presented in ...

Risk factors ID'd for poor cutaneous cell CA outcomes

19 hours ago

(HealthDay)—The risks of metastasis and death associated with cutaneous squamous cell carcinoma (CSCC) are low, but significant, and risk factors for poor outcome include tumor diameter, invasion beyond ...

User comments : 0

More news stories

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

Yahoo Japan suspects 22 million IDs stolen

Yahoo Japan Corp. has said it suspects up to 22 million user IDs may have been stolen during an unauthorised attempt to access the administrative system of its Yahoo! Japan portal.

US seizes Bitcoin operator accounts

US authorities seized the accounts of a Bitcoin digital currency exchange operator, claiming it was functioning as an "unlicensed money service business," court documents showed Friday.

Alaska volcano shoots ash 15,000 feet into the air

(AP)—One of Alaska's most restless volcanoes has shot an ash cloud 15,000 feet into the air in an ongoing eruption that has drawn attention from a nearby community but isn't expected to threaten air traffic.

Chinese, Indian airlines face EU pollution fines

Eight Chinese and two Indian airlines face fines of up to several million euros for not paying for their greenhouse gas emissions during flights within the bloc, the European Commission said on Friday.